Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
Our diversity is vital to providing the highest quality of leadership in our firms, the bar, and the community.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback